Other common side effects of GLP-1s include a sensation of early fullness, reduced appetite, vomiting, and diarrhea
Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
532 Surprisingly, the alkaloid component of aconite has also been shown to inhibit the aberrant expression of inflammatory cytokines (TNF-, IL-1, IL-6, and IFN-) through the MAPK/NF-B/STAT3 signaling pathway, alleviating the symptoms of UC
This sparks discussions on social media surrounding pharmaceutical solutions that dont really happen (outside of illicit drugs), to the point where Ozempic was mentioned at the Oscars in 2023